As to the post’s title, I have no idea. What I do know is that a nice profit is in the books on a suddenly overbought GILD off of Tuesday’s buy. Okay Biotech sector, as you were…
Subscribe to NFTRH Premium for your 40-55 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep up to date with plenty of public content at NFTRH.com and Biiwii.com. Also, you can follow via Twitter @BiiwiiNFTRH, StockTwits, RSS or sign up to receive posts directly by email (right sidebar).
